Table 3.
Proportion of patients achieving adequate control of heartburn, mean number of days per week with heartburn after 2, 4, and 8 weeks of treatment, and median number of antacid tablets consumed
| Variable | Placebo (n=159) | Cisapride (n=163) | Omeprazole (n=161) | P value† |
|---|---|---|---|---|
| Patients (%) achieving adequate control of heartburn* | ||||
| 2 weeks | 15 | 21 | 59 | |
| 4 weeks | 18 | 22 | 71 | <0.0001 |
| 8 weeks | 30 | 40 | 76 | |
| Mean No of days per week with heartburn | ||||
| Baseline | 5.5 | 5.4 | 5.7 | <0.001 |
| 2 weeks | 4.3 | 3.6 | 1.8 | |
| 4 weeks | 3.9 | 3.4 | 1.2 | |
| 8 weeks | 3.5 | 3.0 | 1.0 | |
| Median No of antacid tablets consumed | ||||
| Weeks 1-2 | 13 | 9 | 2 | |
| Weeks 3-4 | 10 | 8 | 0 | <0.0001 |
| Weeks 5-8 | 17 | 12 | 0 | |
No more than mild heartburn for ⩽1 day per week.
Omeprazole v cisapride or placebo.